Trial Profile
Combination therapy with romiplostim, cyclosporine and intravenous immunoglobulin in patients with severe immune thrombocytopenia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 May 2014
Price :
$35
*
At a glance
- Drugs Romiplostim (Primary) ; Ciclosporin; Immune globulin
- Indications Idiopathic thrombocytopenic purpura
- Focus Therapeutic Use
- 14 May 2014 New trial record